Journal
NATURE MEDICINE
Volume 10, Issue 11, Pages 1190-1192Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nm1123
Keywords
-
Funding
- NIA NIH HHS [AG11385, T32 AG00278, AG022074] Funding Source: Medline
- NINDS NIH HHS [NS41787] Funding Source: Medline
Ask authors/readers for more resources
The Arctic mutation within the amyloid-(A) peptide causes Alzheimer disease. In vitro, Arctic-mutant A forms (proto) fibrils more effectively than wild-type A. We generated transgenic mouse lines expressing Arctic-mutant human amyloid precursor proteins (hAPP). Amyloid plaques formed faster and were more extensive in Arctic mice than in hAPP mice expressing wild-type A, even though Arctic mice had lower Abeta(1-42/1-40) ratios. Thus, the Arctic mutation is highly amyloidogenic in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available